ENVERIC BIOSCIENCES, INC. Operating Leases, Future Minimum Payments Due, Next Twelve Months
ENVERIC BIOSCIENCES, INC. (ENVB) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $157.79 thousand as of 2018-12-31, per its 10-K filed 2019-03-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2019-03-26
- 2018-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $157.79K.
- 2017-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $123.87K.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months |
|---|---|
| 2018-12-31 | $157.79K 10-K · filed 2019-03-26 |
| 2017-12-31 | $123.87K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |